Join Bill Hall for a webinar demo of the QuartzBio® enterprise Biomarker Data Management solution. We’ll show you how to generate patient profiles to view tumor burden over course of treatment, explore multi-marker views of patient profiles, and cross-reference biomarker measures across file types.
Join our webinar to learn how our clients, representing major biopharmas and biotechnology companies, have eliminated tedious data management processes and costly delays with the QuartzBio® virtual Sample Inventory Management SaaS solution.
AI/ML can be a powerful, error-reducing tool for managing clinical sample data as well as biomarker data.
AI/ML-based tools should not replace human judgment, particularly for insight generation, at least until AI/ML-based tools are extensively and rigorously validated (as any piece of critical software would be). Furthermore, regulatory compliance and data privacy are of utmost importance and must be considered when building and using solutions that leverage generative AI frameworks.
However, near-term applications of AI/ML can dramatically improve any tedious process involving a human inspecting data. We list some of these processes in the box below, along with steps we recommend taking to reduce risk in each case.
QuartzBio’s Adam S. Brown, PhD, Senior Director of Product Support, will join experts from Washington University and Dana Farber Cancer Institute in a panel discussion,
“Towards Precision Medicine: Oncological Applications of Data Integration” | May 18, 2:40 PM ET
The panelists will share ideas for how to bring oncologists together with data integration leaders to systematically assess factors contributing to disease.
QuartzBio’s team has deep experience in technology-enabled solutions for the life science industry. In this blog series, we invited you to get to know a member of the QuartzBio team. This month, we are delighted to talk with Mike Waters, QuartzBio Vice President of Sales. After learning about Mike here, please feel free to connect […]
Duration: 30 minutes Register to Watch Webinar On Demand: Biomarker data can be time-consuming to clean and prepare for analysis, because assay results data files are often disconnected and have inconsistent formats. This “data chaos” prevents translational, clinical, and bioinformatics teams from extracting insights to advance therapeutic development. Join the webinar led by Adam Brown and […]
Precision for Medicine, the first global, precision medicine, clinical research services organization today announced the strategic acquisition of SolveBio, which will now fall under the QuartzBio, part of Precision for Medicine brand and product portfolio.
Duration: 30 minutes Register to watch on demand: Complex sample operations, disparate vendors, inconsistent metadata across labs are common challenges sponsors face when keeping track of samples across clinical programs. Join our webinar to learn how sponsor teams are creating consistent, portfolio-level approaches for tracking sample status and location and uncovering insights into vendor/site/country-level performance.
Translational and clinical teams spend more than 70% of their time managing, cleaning, and harmonizing data generated in biomarker-rich clinical programs. In a recent webinar, Adam Brown demonstrated how the QuartzBio® enterprise Biomarker Data Management (eBDM) solution addresses one set of frequently intractable challenges: connecting raw, processed, and ancillary data across multiple clinical studies.
Biospecimens collected as part of biomarker-informed clinical programs are precious resources for precision medicine research and development (R&D). However, the complexity of tracking and linking informed consent data at the sample and derivative levels limits the use of these biospecimens. In this post, we’ll explore how clinical teams can benefit from QuartzBio’s flexible approach to ICF codification to reduce complexity, gain more value from their stored samples, and help turn their biorepositories into drug development engines.
Precision for Medicine is the first biomarker-driven clinical development organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments. Precision for Medicine is part of Precision Medicine Group, with 3,000 employees in 40 locations.
QUARTZBIO® and the PRECISION QUARTZBIO® logo are registered trademarks of Precision Medicine Group, LLC in the United States and/or other jurisdictions. All rights reserved.
© 2024. All rights reserved.
Precision Medicine Group, LLC.
Privacy Policy | GDPR
Web Design and Development by RainCastle Communications.